|
|
 |
|
Total Number of Holdings (excluding cash): 50
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
973 |
$81,391.45 |
2.37% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,623 |
$79,232.89 |
2.31% |
| Teleflex Incorporated |
TFX |
879369106 |
511 |
$79,358.30 |
2.31% |
| Align Technology, Inc. |
ALGN |
016255101 |
448 |
$78,068.48 |
2.27% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
751 |
$78,111.51 |
2.27% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
718 |
$77,055.76 |
2.24% |
| Steris Plc |
STE |
G8473T100 |
298 |
$76,621.76 |
2.23% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
592 |
$76,635.80 |
2.23% |
| LivaNova Plc |
LIVN |
G5509L101 |
837 |
$76,284.18 |
2.22% |
| Alcon Inc. |
ALC.SW |
H01301128 |
1,001 |
$75,044.69 |
2.18% |
| Stryker Corporation |
SYK |
863667101 |
231 |
$74,910.99 |
2.18% |
| The Cooper Companies, Inc. |
COO |
216648501 |
1,176 |
$74,758.32 |
2.18% |
| Cochlear Limited |
COH.AU |
Q25953102 |
714 |
$74,705.88 |
2.17% |
| Becton, Dickinson and Company |
BDX |
075887109 |
348 |
$73,988.28 |
2.15% |
| Medtronic Plc |
MDT |
G5960L103 |
723 |
$73,449.57 |
2.14% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
5,434 |
$72,779.55 |
2.12% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
4,739 |
$71,992.73 |
2.10% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
175 |
$72,196.25 |
2.10% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
41 |
$71,806.58 |
2.09% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
980 |
$71,575.27 |
2.08% |
| Abbott Laboratories |
ABT |
002824100 |
642 |
$70,915.32 |
2.06% |
| BioMerieux |
BIM.FP |
F1149Y232 |
687 |
$70,285.97 |
2.05% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$70,518.59 |
2.05% |
| Insulet Corporation |
PODD |
45784P101 |
473 |
$70,032.38 |
2.04% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,460 |
$69,983.29 |
2.04% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
97 |
$69,665.40 |
2.03% |
| Waters Corporation |
WAT |
941848103 |
147 |
$69,901.44 |
2.03% |
| Baxter International Inc. |
BAX |
071813109 |
2,627 |
$69,405.34 |
2.02% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,251 |
$68,932.30 |
2.01% |
| Danaher Corporation |
DHR |
235851102 |
291 |
$68,708.01 |
2.00% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
201 |
$68,282.53 |
1.99% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
151 |
$67,956.04 |
1.98% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
175 |
$67,634.00 |
1.97% |
| Boston Scientific Corporation |
BSX |
101137107 |
1,497 |
$66,915.90 |
1.95% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
268 |
$66,833.97 |
1.95% |
| Agilent Technologies, Inc. |
A |
00846U101 |
375 |
$66,705.00 |
1.94% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,762 |
$66,363.68 |
1.93% |
| Revvity, Inc. |
RVTY |
714046109 |
415 |
$66,026.50 |
1.92% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,392 |
$65,060.94 |
1.89% |
| ResMed Inc. |
RMD |
761152107 |
278 |
$65,082.58 |
1.89% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
857 |
$64,472.11 |
1.88% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
733 |
$64,364.73 |
1.87% |
| Penumbra, Inc. |
PEN |
70975L107 |
200 |
$64,292.00 |
1.87% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
793 |
$62,662.86 |
1.82% |
| DexCom, Inc. |
DXCM |
252131107 |
760 |
$60,739.20 |
1.77% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,377 |
$60,717.60 |
1.77% |
| Hoya Corporation |
7741.JP |
J22848105 |
394 |
$58,339.58 |
1.70% |
| Olympus Corporation |
7733.JP |
J61240107 |
5,040 |
$56,283.86 |
1.64% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$44,544.86 |
1.30% |
| US Dollar |
$USD |
|
23,169 |
$23,169.00 |
0.67% |
| Japanese Yen |
$JPY |
|
165,348 |
$1,041.37 |
0.03% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
| Pound Sterling |
$GBP |
|
-410 |
($546.52) |
-0.02% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|